Pathology and pathogenetic mechanisms of diabetic neuropathy.

[1]  H. Yasuda,et al.  Effect of Prostaglandin E1 Analogue TFC 612 on Diabetic Neuropathy in Streptozocin-Induced Diabetic Rats Comparison With Aldose Reductase Inhibitor ONO 2235 , 1989, Diabetes.

[2]  P. Dyck,et al.  Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy , 1986, Annals of neurology.

[3]  P. K. Thomas,et al.  Diabetic Neuropathy: Models, Mechanisms and Mayhem , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  S. Fagerberg.  Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. , 1959, Acta medica Scandinavica. Supplementum.

[5]  P. Raskin,et al.  Crucial Role of Aldose Reductase Activity and Plasma Glucose Level in Sorbitol Accumulation in Erythrocytes From Diabetic Patients , 1991, Diabetes.

[6]  A. Windebank,et al.  Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity , 1981, Experimental Neurology.

[7]  I. Ford,et al.  Relationships between Haemostatic Factors and Capillary Morphology in Human Diabetic Neuropathy , 1992, Thrombosis and Haemostasis.

[8]  C. Hock,et al.  Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation , 1991, Neuroscience Letters.

[9]  F. DeRubertis,et al.  Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. , 1989, The Journal of clinical investigation.

[10]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[11]  R. Wada,et al.  Galactosemic Neuropathy in Transgenic Mice for Human Aldose Reductase , 1996, Diabetes.

[12]  R. Friede,et al.  Relation between the number of myelin lamellae and axon circumference in fibers of vagus and sciatic nerves of mice , 1967, The Journal of comparative neurology.

[13]  M. Bitensky,et al.  Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Thomas,et al.  Peripheral Nerve Abnormalities in the Diabetic Mutant Mouse , 1983, Diabetes.

[15]  R. Sorenson,et al.  Immunohistochemical Localization of Aldose Reductase: I. Enzyme Purification and Antibody Preparation—Localization in Peripheral Nerve, Artery, and Testis , 1980, Diabetes.

[16]  J. Sotelo,et al.  Low serum levels of nerve growth factor in diabetic neuropathy , 1990, Acta neurologica Scandinavica.

[17]  C. Kilo,et al.  Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. , 1988, Diabetes/metabolism reviews.

[18]  S. Yagihashi,et al.  Effects of Long-Term Aldose Reductase Inhibition on Development of Experimental Diabetic Neuropathy: Ultrastructural and Morphometric Studies of Sural Nerve in Streptozocin-Induced Diabetic Rats , 1990, Diabetes.

[19]  S. Yagihashi,et al.  Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin-deficient BB rat. , 1984, The American journal of physiology.

[20]  P. Dyck,et al.  Spatial Distribution of Fiber Degeneration in Acute Hypoglycemic Neuropathy in Rat , 1991, Journal of neuropathology and experimental neurology.

[21]  N. Calcutt,et al.  Inhibition of Macrophage Chemotaxis and Peripheral Nerve Regeneration in Normal and Hyperglycemic Rats by the Aldose Reductase Inhibitor Tolrestat , 1994, Experimental Neurology.

[22]  P. Low,et al.  Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Slama,et al.  Progressive centripetal degeneration of axons in small fibre diabetic polyneuropathy. , 1983, Brain : a journal of neurology.

[24]  P. Kern,et al.  Age related changes of capillary basement membrane. , 1974, Pathologie-biologie.

[25]  S. Chakrabarti,et al.  Effect of Insulin and Statil on Aldose Reductase Expression in Diabetic Rats , 1991, Diabetes.

[26]  A. Boulton,et al.  Nerve Ischaemia‐Resistance: An early Abnormality in Diabetes , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[27]  J. Ward,et al.  Electron microscopical studies of vessels in diabetic peripheral neuropathy. , 1980, Journal of clinical pathology.

[28]  M. Brownlee.  Glycation and Diabetic Complications , 1994, Diabetes.

[29]  P. Dyck,et al.  Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy , 1982, Journal of the Neurological Sciences.

[30]  R. Myers,et al.  Galactose neuropathy: Impact of chronic endoneurial edema on nerve blood flow , 1984, Annals of neurology.

[31]  S. Chakrabarti,et al.  The BB-rat--an authentic model of human diabetic retinopathy. , 1985, Current eye research.

[32]  D. Tomlinson,et al.  Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor , 1989, Journal of the Neurological Sciences.

[33]  D. Dvornik,et al.  Prevention of Basement Membrane Thickening in Retinal Capillaries by a Novel Inhibitor of Aldose Reductase, Tolrestat , 1986, Diabetes.

[34]  S. Darby,et al.  Blood glucose control and glomerular capillary basement membrane thickening in experimental diabetes. , 1977, British medical journal.

[35]  Peter C Johnson,et al.  Pathogenesis of diabetic neuropathy , 1986, Annals of neurology.

[36]  S. Chakrabarti,et al.  Increased Renal Aldose Reductase Activity, Immunoreactivity, and mRNA in Streptozocin-Induced Diabetic Rats , 1989, Diabetes.

[37]  A. Cerami,et al.  Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. , 1988, Diabetes/metabolism reviews.

[38]  C. Servo,et al.  Myoinositol and function of peripheral nerves in human diabetics A CONTROLLED CLINICAL TRIAL , 1978, Acta neurologica Scandinavica.

[39]  A. Sima,et al.  Diabetic Neuropathy in the Mutant Mouse [C57BL/ks(db/db)]: A Morphometric Study , 1980, Diabetes.

[40]  C J Watkins,et al.  Innervation of the Vasa Nervorum: Changes in Human Diabetics , 1992, Journal of neuropathology and experimental neurology.

[41]  P. Kador.  The role of aldose reductase in the development of diabetic complications , 1988, Medicinal research reviews.

[42]  B. Shahani,et al.  Diabetes mellitus presenting with bilateral foot-drop. , 1969, Lancet.

[43]  P. Sidenius,et al.  Slow Component-a of Axonal Transport, Nerve myo-Inositol, and Aldose Reductase Inhibition in Streptozocin-Diabetic Rats , 1986, Diabetes.

[44]  P. Dyck,et al.  Ultrastructural Morphometric Features of Human Sural Nerve Endoneurial Microvessels , 1993, Journal of neuropathology and experimental neurology.

[45]  P J Dyck,et al.  Hypoxic neuropathy Does hypoxia play a role in diabetic neuropathy? , 1989, Neurology.

[46]  S. Plurad,et al.  Experimental diabetic autonomic neuropathy characterization in streptozotocin-diabetic Sprague-Dawley rats. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[47]  E. Ellis,et al.  Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. , 1991, Metabolism: clinical and experimental.

[48]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Greene,et al.  Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. , 1983, The Journal of clinical investigation.

[50]  P. Low,et al.  Oxygen Free Radical Effects in Sciatic Nerve in Experimental Diabetes , 1991, Diabetes.

[51]  P. Thomas,et al.  Peripheral Nerve Fiber Size in Experimental Diabetes , 1977, Diabetes.

[52]  D. Greene,et al.  Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol. , 1987, The Journal of clinical investigation.

[53]  D. B. Martin,et al.  Has one diabetic complication been explained? , 1983, The New England journal of medicine.

[54]  P. Dyck,et al.  The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia , 1986, Annals of neurology.

[55]  K. Gabbay.  The sorbitol pathway and the complications of diabetes. , 1973, The New England journal of medicine.

[56]  M. E. Clark,et al.  Living with water stress: evolution of osmolyte systems. , 1982, Science.

[57]  A. Windebank,et al.  Capillary number and percentage closed in human diabetic sural nerve. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[58]  A. Cerami,et al.  Glucose and aging. , 1987, Scientific American.

[59]  D. Greene,et al.  Endoneurial Microvessels in Human Diabetic Neuropathy: Endothelial Cell Dysjunction and Lack of Treatment Effect by Aldose Reductase Inhibitor , 1991, Diabetes.

[60]  C. L. Dolman.  The morbid anatomy of diabetic neuropathy , 1963, Neurology.

[61]  N. Calcutt,et al.  Statil-sensitive polyol formation in nerve of galactose-fed mice. , 1988, Metabolism: clinical and experimental.

[62]  Bond Ca,et al.  Developmental and Physiological Regulation of Aldose Reductase mRNA Expression in Renal Medulla , 1989 .

[63]  T. Kern,et al.  Kidney Morphology in Experimental Hyperglycemia , 1987, Diabetes.

[64]  W. Schady,et al.  Endoneurial capillary abnormalities in mild human diabetic neuropathy. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[65]  A. Bischoff.  [Diabetic neuropathy. Pathologic anatomy, pathophysiology and pathogenesis on the basis of electron microscopic studies]. , 1968, Deutsche medizinische Wochenschrift.

[66]  P. Thomas,et al.  Nerve conduction velocity in experimental diabetes in the rat and rabbit. , 1981, Journal of neurology, neurosurgery, and psychiatry.

[67]  A. Bischoff.  Ultrastructural pathology of periperal nervous system in early diabetes. , 1973, Advances in metabolic disorders.

[68]  D. Price,et al.  THE PATHOGENESIS OF REACTIVE AXONAL SWELLINGS: ROLE OF AXONAL TRANSPORT , 1977, Journal of neuropathology and experimental neurology.

[69]  C. Kilo,et al.  Mechanisms of Glucose- and Diabetes-Induced Vascular Dysfunction , 1992 .

[70]  T. Brismar,et al.  Reversible and irreversible nodal dysfunction in diabetic neuropathy , 1987, Annals of neurology.

[71]  C. Nishimura,et al.  The involvement of aldose reductase in diabetic complications. , 1988, Diabetes/metabolism reviews.

[72]  P. Low.  Recent advances in the pathogenesis of diabetic neuropathy. Clues from human diabetic neuropathy , 1987, Muscle & nerve.

[73]  E. Lillehoj,et al.  Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations. , 1986, Experimental pathology.

[74]  A. Shore,et al.  Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. , 1992, The New England journal of medicine.

[75]  R. Schmidt,et al.  The Effect of Pancreatic Islet Transplantation and Insulin Therapy on Experimental Diabetic Autonomic Neuropathy , 1983, Diabetes.

[76]  T. Onaya,et al.  The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. , 1992, The Journal of clinical endocrinology and metabolism.

[77]  M. Cotter,et al.  The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. , 1994, Diabetes/metabolism reviews.

[78]  D. Neary,et al.  THE PATHOLOGY OF ULNAR NERVE COMPRESSION IN MAN , 1975 .

[79]  A. Gorio,et al.  Axonal transport of acetylcholinesterase in the diabetic mutant mouse , 1983, Experimental Neurology.

[80]  Y. Olsson,et al.  A patho-anatomical study of the central and peripheral nervous system in diabetes of early onset and long duration. , 1968, Pathologia Europaea.

[81]  S. Yagihashi,et al.  Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. , 1979, The Tohoku journal of experimental medicine.

[82]  D Stribling,et al.  Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. , 1985, Metabolism: clinical and experimental.

[83]  L. Rosner,et al.  The neuropathy of hypoglycemia , 1964, Neurology.

[84]  J. Harlow,et al.  Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+. , 1992, Kidney international.

[85]  D. Finegold,et al.  A defect in sodium-dependent amino acid uptake in diabetic rabbit peripheral nerve. Correction by an aldose reductase inhibitor or myo-inositol administration. , 1990, The Journal of clinical investigation.

[86]  J. Hanker,et al.  PERIPHERAL NEUROPATHY IN MOUSE HEREDITARY DIABETES MELLITUS. II. ULTRASTRUCTURAL CORRELATES OF DEGENERATIVE AND REGENERATIVE CHANGES , 1980, Neuropathology and applied neurobiology.

[87]  G. King,et al.  Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. , 1994, The American journal of physiology.

[88]  L. Autilio‐Gambetti,et al.  Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy , 1988, Neurology.

[89]  D. Tomlinson,et al.  Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol , 1985, Experimental Neurology.

[90]  P. Dyck,et al.  Chronic Hypoxia Induces Selective Maldevelopment of Peripheral Myelin in Rat , 1988, Journal of neuropathology and experimental neurology.

[91]  P. Thomas,et al.  Aldose reductase activity and myo-inositol levels in sciatic nerve and dorsal root ganglia of the diabetic mutant mouse [C57/BL/Ks (db/db)]. , 1991, Metabolism: clinical and experimental.

[92]  D. Greene,et al.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. , 1988, The Journal of clinical investigation.

[93]  J. Dunlap,et al.  L‐Fucose Is a Potent Inhibitor of myo‐Inositol Transport and Metabolism in Cultured Neuroblastoma Cells , 1992, Journal of neurochemistry.

[94]  E. Cagliero,et al.  Characteristics and Mechanisms of High-Glucose–Induced Overexpression of Basement Membrane Components in Cultured Human Endothelial Cells , 1991, Diabetes.

[95]  P. Dyck,et al.  Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy , 1987, Neurology.

[96]  A. Nimalasuriya,et al.  A case of insulinoma with peripheral neuropathy. , 1983, Postgraduate medical journal.

[97]  Peter C Johnson,et al.  Transperineurial Arterioles in Human Sural Nerve , 1991, Journal of neuropathology and experimental neurology.

[98]  D. Greene,et al.  Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes. , 1975, The Journal of clinical investigation.

[99]  C. Kilo,et al.  Muscle Capillary Basement Membrane Changes Related to Aging and to Diabetes Mellitus , 1972, Diabetes.

[100]  A. Sima,et al.  FUNCTIONAL ASPECTS AND PATHOGENETIC CONSIDERATIONS OF THE NEUROPATHY IN THE SPONTANEOUSLY DIABETIC BB‐WISTAR RAT , 1981, Neuropathology and applied neurobiology.

[101]  S. Yagihashi,et al.  Central-peripheral distal axonopathy in the spontaneously diabetic BB-rat: ultrastructural and morphometric findings. , 1985, Diabetes research and clinical practice.

[102]  H. Nukada.  Mild ischemia causes severe pathological changes in experimental diabetic nerve , 1992, Muscle & nerve.

[103]  F. Buchthal,et al.  Nerve biopsy and conduction studies in diabetic neuropathy. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[104]  P. Low,et al.  Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. , 1986, The American journal of physiology.

[105]  S. Yagihashi,et al.  Peripheral neuropathy in selectively-inbred spontaneously diabetic rats: electrophysiological, morphometrical and freeze-replica studies. , 1982, The Tohoku journal of experimental medicine.

[106]  T. Onaya,et al.  Cyclic adenosine 3',5'-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats. , 1993, Endocrinology.

[107]  S. Yagihashi,et al.  Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Nerve of STZ-Induced Diabetic Rats , 1992, Diabetes.

[108]  D. Greene,et al.  Altered Sorbitol and myo‐Inositol Metabolism as the Basis for Defective Protein Kinase C and (Na,K)‐ATPase Regulation in Diabetic Neuropathy a , 1986, Annals of the New York Academy of Sciences.

[109]  R. Schmidt,et al.  Axonal Dystrophy in Experimental Diabetic Autonomic Neuropathy , 1982, Diabetes.

[110]  A. Winegrad.  Banting Lecture 1986: Does a Common Mechanism Induce the Diverse Complications of Diabetes? , 1987, Diabetes.

[111]  P. Thomas,et al.  The effect of insulin treatment on myelinated nerve fibre maturation and integrity and on body growth in streptozotocin-diabetic rats , 1985, Journal of the Neurological Sciences.

[112]  A. Sima,et al.  Diabetic Neuropathy in STZ-Induced Diabetic Rat and Effect of Allogeneic Islet Cell Transplantation: Morphometric Analysis , 1988, Diabetes.

[113]  K. Pritchard,et al.  Restoration of Prostacyclin/Thromboxane A2 Balance in the Diabetic Rat: Influence of Dietary Vitamin E , 1982, Diabetes.

[114]  S. Radner.  Atrioventricular activity as reflected in suprasternal pressure curves. , 2009, Acta medica Scandinavica.

[115]  E. Feldman,et al.  The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. , 1994, The Journal of clinical investigation.

[116]  T. Toyota,et al.  The significance of nerve sugar levels for the peripheral nerve impairment of spontaneously diabetic GK (Goto-Kakizaki) rats. , 1990, Diabetes research (Edinburgh, Scotland).

[117]  S. Chakrabarti,et al.  Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. , 1990, The Journal of clinical investigation.

[118]  D. Greene,et al.  Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. , 1987, The New England journal of medicine.

[119]  P K Thomas,et al.  Peripheral nerve structure and function in experimental diabetes. , 1974, Journal of the neurological sciences.

[120]  A. Cerami,et al.  The biochemistry of the complications of diabetes mellitus. , 1981, Annual review of biochemistry.

[121]  J. Jakobsen,et al.  Early and preventable changes of peripheral nerve structure and function in insulin-deficient diabetic rats. , 1979, Journal of neurology, neurosurgery, and psychiatry.

[122]  D. Archer,et al.  A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. , 1985, American journal of ophthalmology.

[123]  H. Federoff,et al.  Nonenzymatic Glycosylation of Laminin and the Laminin Peptide CIKVAVS Inhibits Neurite Outgrowth , 1993, Diabetes.

[124]  R. Hellweg,et al.  Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy , 1990, Journal of neuroscience research.

[125]  E. Feldman,et al.  Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. , 1993, Diabetes/metabolism reviews.

[126]  M. Cotter,et al.  Effects of Chronic α-Adrenergic Receptor Blockade on Peripheral Nerve Conduction, Hypoxic Resistance, Polyols, Na+-K+-ATPase Activity, and Vascular Supply in STZ-D Rats , 1991, Diabetes.

[127]  P. Thomas,et al.  The effect of continuous subcutaneous insulin infusion therapy on morphological and biochemical abnormalities of peripheral nerves in experimental diabetes , 1986, Journal of the Neurological Sciences.

[128]  P. Low,et al.  Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. , 1989, Brain : a journal of neurology.

[129]  R. Balaban,et al.  Predominant osmotically active organic solutes in rat and rabbit renal medullas. , 1986, The Journal of biological chemistry.

[130]  M. Mcdaniel,et al.  Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction , 1992, Diabetes.

[131]  D. Anthony,et al.  3,4-Dimethyl-2,5-hexanedione impairs the axonal transport of neurofilament proteins , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[132]  M. Province,et al.  Modulation of Hemodynamic and Vascular Filtration Changes in Diabetic Rats by Dietary myo-inositol , 1990, Diabetes.

[133]  P. Dyck,et al.  Axonal Caliber and Neurofilaments are Proportionately Decreased in Galactose Neuropathy , 1986, Journal of neuropathology and experimental neurology.

[134]  W. Tetzlaff,et al.  Influence of nerve growth factor on neurofilament gene expression in mature primary sensory neurons , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[135]  R. Clements.  Diabetic Neuropathy—New Concepts of Its Etiology , 1979, Diabetes.

[136]  T. Onaya,et al.  Effects of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes. , 1991, Prostaglandins, leukotrienes, and essential fatty acids.

[137]  Mara,et al.  High glucose induces DNA damage in cultured human endothelial cells. , 1986, The Journal of clinical investigation.

[138]  R. Myers,et al.  Schwann cell changes and demyelination in chronic galactose neuropathy , 1983, Muscle & nerve.

[139]  N. Calcutt,et al.  Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve. , 1994, European journal of pharmacology.

[140]  J. Pirart.  Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973 , 1978, Diabetes Care.

[141]  D. Greene,et al.  Diabetic and hypoglycemic neuropathy--a comparison in the BB rat. , 1989, Diabetes research and clinical practice.

[142]  K. Nicholls,et al.  Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[143]  L. Autilio‐Gambetti,et al.  Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[144]  M. Province,et al.  Prevention of Hemodynamic and Vascular Albumin Filtration Changes in Diabetic Rats by Aldose Reductase Inhibitors , 1989, Diabetes.

[145]  P. Thomas,et al.  Influence of dietary myoinositol on nerve conduction and inositol phospholipids in normal and diabetic rats. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[146]  E. Marliss,et al.  The Spontaneously Diabetic Wistar Rat: Metabolic and Morphologic Studies , 1977, Diabetes.

[147]  P. Low,et al.  Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. , 1991, The American journal of physiology.

[148]  J. Dunlap,et al.  Reduced Motor Nerve Conduction Velocity and Na+-K+-ATPase Activity in Rats Maintained on L-Fucose Diet: Reversal by myo-Inositol Supplementation , 1993, Diabetes.

[149]  S. Yagihashi,et al.  Diabetic autonomic neuropathy. The distribution of structural changes in sympathetic nerves of the BB rat. , 1985, The American journal of pathology.

[150]  R. Vracko.  A Comparison of the Microvascular Lesions in Diabetes Mellitus with Those in Normal Aging , 1982, Journal of the American Geriatrics Society.

[151]  T. Lagerlund,et al.  Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. , 1989, International review of neurobiology.

[152]  S. Brimijoin,et al.  Slow axonal transport in experimental hypoxia and in neuropathy induced by p-bromophenylacetylurea , 1987, Brain Research.

[153]  B. Cowley,et al.  Feedback inhibition of aldose reductase gene expression in rat renal medulla. Galactitol accumulation reduces enzyme mRNA levels and depletes cellular inositol content. , 1990, The Journal of clinical investigation.

[154]  M. Cotter,et al.  Essential Fatty Acid Diet Supplementation: Effects on Peripheral Nerve and Skeletal Muscle Function and Capillarization in Streptozocin-Induced Diabetic Rats , 1991, Diabetes.

[155]  M. Furue,et al.  Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Immunoassay of human aldose reductase. , 1993, Biochemical pharmacology.

[156]  N. Calcutt,et al.  Coexistence of Nerve Conduction Deficit With Increased Na+-K+-ATPase Activity in Galactose-Fed Mice: Implications for Polyol Pathway and Diabetic Neuropathy , 1990, Diabetes.

[157]  T. Orchard.  From Diagnosis and Classification to Complications and Therapy: DCCT Part II? , 1994, Diabetes Care.

[158]  P. Thomas,et al.  SCHWANN-CELL ABNORMALITIES IN DIABETIC NEUROPATHY. , 1965, Lancet.

[159]  R. Vracko,et al.  BASAL LAMINA: THE SCAFFOLD FOR ORDERLY CELL REPLACEMENT , 1972, The Journal of cell biology.

[160]  A. Shore,et al.  Capillary Pressure in Patients With NIDDM , 1994, Diabetes.

[161]  P. C. Richardson,et al.  PATHOLOGICAL OBSERVATIONS ON SIX CASES OF DIABETIC NEUROPATHY. , 1964, Brain : a journal of neurology.

[162]  D. Tomlinson,et al.  The pharmacology of diabetic neuropathy. , 1992, Diabetes/metabolism reviews.

[163]  P. Thomas,et al.  THE PATHOLOGY OF DIABETIC NEUROPATHY , 1966 .

[164]  S. Yagihashi,et al.  Neuroaxonal and Dendritic Dystrophy in Diabetic Autonomic Neuropathy. Classification and Topographic Distribution in the BB‐Rat , 1986, Journal of neuropathology and experimental neurology.

[165]  P. Corr,et al.  Neural Dysfunction and Metabolic Imbalances in Diabetic Rats: Prevention by Acetyl-L-Carnitine , 1994, Diabetes.

[166]  A. Cerami,et al.  Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[167]  G. Gregersen.  Diabetic neuropathy , 1967, Neurology.

[168]  M. Mcdaniel,et al.  Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.

[169]  J. Jakobsen,et al.  Neuropathy in experimental diabetes: an animal model. , 1976, British medical journal.

[170]  J W Griffin,et al.  Control of axonal caliber by neurofilament transport , 1984, The Journal of cell biology.

[171]  J. Jakobsen,et al.  Peripheral Neuropathy in Rats Induced by Insulin Treatment , 1983, Diabetes.

[172]  J. Jakobsen,et al.  Decreased axonal transport of structural proteins in streptozotocin diabetic rats. , 1980, The Journal of clinical investigation.

[173]  N. Solenski,et al.  Enhanced vesicular ingestion of nonenzymatically glucosylated proteins by capillary endothelium. , 1984, Microvascular research.

[174]  J. Jakobsen,et al.  Axonal transport in early experimental diabetes , 1979, Brain Research.

[175]  E. Feldman,et al.  Complications: Neuropathy, Pathogenetic Considerations , 1992, Diabetes Care.

[176]  D. Felten,et al.  A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats , 1980, Journal of the Neurological Sciences.

[177]  D. Felten,et al.  Neuropathic changes associated with insulin treatment of diabetic rats: Electron microscopic and morphometric analysis , 1983, Brain Research Bulletin.

[178]  P. Dyck,et al.  Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus , 1994, Annals of neurology.

[179]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[180]  A. Cerami,et al.  Excessive Nonenzymatic Glycosylation of Peripheral and Central Nervous System Myelin Components in Diabetic Rats , 1983, Diabetes.

[181]  Merete Schmiegelow,et al.  Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals * , 1983, Acta neurologica Scandinavica.

[182]  G. Slama,et al.  Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study. , 1992, The New England journal of medicine.

[183]  P. Sidenius,et al.  Slow Axonal Transport of Structural Polypeptides in Rat, Early Changes in Streptozocin Diabetes, and Effect of Insulin Treatment , 1989, Journal of neurochemistry.

[184]  G. Burnstock,et al.  The nerves to blood vessels supplying blood to nerves: the innervation of vasa nervorum , 1984, Brain Research.

[185]  J W Griffin,et al.  Neurofilament gene expression: a major determinant of axonal caliber. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[186]  J. Nyengaard,et al.  Inhibition of Sorbitol Dehydrogenase: Effects on Vascular and Neural Dysfunction in Streptozocin-Induced Diabetic Rats , 1995, Diabetes.

[187]  J. Kinoshita,et al.  Role of aldose reductase in the development of diabetes-associated complications. , 1985, The American journal of medicine.

[188]  J. Jaspan,et al.  Hypoglycemic Peripheral Neuropathy in Association with Insulinoma: Implication of Glucopenia Rather Than Hyperinsulinism Case Report and Literature Review , 1982, Medicine.

[189]  R. Schmidt,et al.  Effects of Sorbinil, Dietary myo-Inositol Supplementation, and Insulin on Resolution of Neuroaxonal Dystrophy in Mesenteric Nerves of Streptozocin-Induced Diabetic Rats , 1991, Diabetes.

[190]  H. Buchwald,et al.  Nonenzymatic Glycation of Fibronectin and Alterations in the Molecular Association of Cell Matrix and Basement Membrane Components in Diabetes Mellitus , 1985, Diabetes.

[191]  A. Maunsbach,et al.  Ultrastructure of the sodium pump: Comparison of thin sectioning, negative staining, and freeze-fracture of purified, membrane-bound (Na+, K+)-ATPase , 1977, The Journal of cell biology.

[192]  A. Messing,et al.  Peripheral Neuropathy Associated with Functional Islet Cell Adenomas in SV40 Transgenic Mice , 1989, Journal of neuropathology and experimental neurology.

[193]  J. Jakobsen,et al.  Anterograde Fast Component of Axonal Transport During Insulin-Induced Hypoglycemia in Nondiabetic and Diabetic Rats , 1987, Diabetes.

[194]  B. Wolf,et al.  Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. , 1991, The Journal of clinical investigation.

[195]  G. Burnstock,et al.  Adrenergic innervation of vasa and nervi nervorum of optic, sciatic, vagus and sympathetic nerve trunks in normal and streptozotocin-diabetic rats , 1986, Brain Research.

[196]  G. King,et al.  Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. , 1989, The Journal of clinical investigation.

[197]  J. Richardson,et al.  Hypoglycaemia from islet cell tumor of pancreas with amyotrophy and cerebrospinal nerve cell changes; a case report. , 1951, Journal of neuropathology and experimental neurology.

[198]  D. Greene,et al.  Protein Kinase C Agonists Acutely Normalize Decreased Ouabain-inhibitable Respiration in Diabetic Rabbit Nerve: Implications for (Na,K)-ATPase Regulation and Diabetic Complications , 1986, Diabetes.

[199]  D. W. Mulder,et al.  The neuropathies associated with diabetes mellitus , 1961, Neurology.

[200]  P. Thomas,et al.  Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[201]  R. Kikkawa,et al.  Amelioration of Nerve Na+-K+-ATPase Activity Independently of myo-Inositol Level by PGE1 Analogue OP-1206 · α-CD in Streptozocin-Induced Diabetic Rats , 1991, Diabetes.

[202]  P. Thomas,et al.  Peripheral nerve abnormalities related to galactose administration in rats. , 1976, Journal of neurology, neurosurgery, and psychiatry.

[203]  P. Raskin,et al.  Glycemic Control and Diabetic Complications , 1992, Diabetes Care.

[204]  G. Davies-Jones,et al.  Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. , 1985, Journal of clinical pathology.

[205]  A. Mizisin,et al.  Cellular Pathology of the Nerve Microenvironment in Galactose Intoxication , 1991, Journal of neuropathology and experimental neurology.

[206]  J. Nyengaard,et al.  Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.

[207]  G. Danta.  Hypoglycemic peripheral neuropathy. , 1969, Archives of neurology.

[208]  S. Yagihashi,et al.  Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats. , 1990, The American journal of pathology.

[209]  A. Sima,et al.  Axonal atrophy in sensory nerves of the diabetic BB‐Wistar rat: A possible early correlate of human diabetic neuropathy , 1983, Annals of neurology.

[210]  J. Daube,et al.  Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. , 1985, Brain : a journal of neurology.

[211]  R. Friede,et al.  Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice , 1970, The Anatomical record.

[212]  S. Rapoport,et al.  Distribution of adrenergic innervation of blood vessels in peripheral nerve , 1986, Brain Research.

[213]  S. Kasayama,et al.  Impaired production of nerve growth factor in the submandibular gland of diabetic mice. , 1989, The American journal of physiology.

[214]  T Tanimoto,et al.  Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. , 1991, Biochimica et biophysica acta.

[215]  S. Furukawa,et al.  Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats , 1992, Experimental Neurology.

[216]  R. Vracko,et al.  CAPILLARY BASAL LAMINA THICKENING : Its Relationship to Endothelial Cell Death and Replacement , 1970 .

[217]  P. Fernyhough,et al.  Reduced Levels of mRNA Encoding Endoskeletal and Growth-Associated Proteins in Sensory Ganglia in Experimental Diabetes , 1995, Diabetes.

[218]  J. Chopra,et al.  The pathogenesis of sural nerve changes in diabetes mellitus. , 1969, Brain : a journal of neurology.

[219]  A. Windebank,et al.  Interstitial Hyperosmolarity May Cause Axis Cylinder Shrinkage in Streptozotocin Diabetic Nerve , 1980, Journal of neuropathology and experimental neurology.

[220]  D. Tomlinson,et al.  Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes , 1985, Experimental Neurology.

[221]  Y. Gotō,et al.  Spontaneous Diabetes Produced by Selective Breeding of Normal Wistar Rats , 1975 .

[222]  M. Cohen,et al.  In vivo biosynthesis and turnover of glomerular basement membrane in diabetic rats. , 1982, The American journal of physiology.

[223]  N. Hotta,et al.  Effect of Niceritrol on Streptozocin-Induced Diabetic Neuropathy in Rats , 1992, Diabetes.

[224]  S. Yagihashi,et al.  Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. , 1986, The Journal of clinical investigation.

[225]  Calvin G. Barnes,et al.  Improvement in nerve conduction following treatment in newly diagnosed diabetics. , 1971, Lancet.

[226]  P J Dyck,et al.  Intima of epineurial arterioles is increased in diabetic polyneuropathy , 1988, Neurology.

[227]  S. Bursell,et al.  Normalization of Diacylglycerol-Protein Kinase C Activation by Vitamin E in Aorta of Diabetic Rats and Cultured Rat Smooth Muscle Cells Exposed to Elevated Glucose Levels , 1994, Diabetes.

[228]  R. Engerman,et al.  Experimental Diabetic Microangiopathy: 1. Basement Membrane Statistics in the Dog , 1969, Diabetes.

[229]  T Brismar,et al.  Reversible diabetic nerve dysfunction: Structural correlates to electrophysiological abnormalities , 1985, Annals of neurology.

[230]  Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[231]  J. Jakobsen,et al.  Reversibility and Preventability of the Decrease in Slow Axonal Transport Velocity in Experimental Diabetes , 1982, Diabetes.

[232]  C. Nishimura,et al.  Depletion of myo‐Inositol and Amino Acids in Galactosemic Neuropathy , 1987, Journal of neurochemistry.

[233]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[234]  D. Greene,et al.  Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis. , 1976, The New England journal of medicine.

[235]  H. Nukada.  Increased Susceptibility to Ischemic Damage in Steptozocin-Diabetic Nerve , 1986, Diabetes.

[236]  P. Dyck,et al.  Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[237]  J. Arezzo,et al.  Nerve growth factor administration protects against experimental diabetic sensory neuropathy , 1994, Brain Research.

[238]  D. Felten,et al.  Degenerative neuropathy in insulin-treated diabetic rats , 1983, Journal of the Neurological Sciences.

[239]  S. Britland,et al.  Relationship of Endoneurial Capillary Abnormalities to Type and Severity of Diabetic Polyneuropathy , 1990, Diabetes.

[240]  H. W. Woltman,et al.  DIABETES MELLITUS: PATHOLOGIC CHANGES IN THE SPINAL CORD AND PERIPHERAL NERVES , 1929 .

[241]  D. O'Leary,et al.  Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 2. Effect of streptozotocin-induced diabetes. , 1990, Acta neuropathologica.

[242]  A. Asbury,et al.  Painful diabetic neuropathy. A morphometric study. , 1976, Archives of neurology.